COVID-19 in Africa tracker
The Foundation’s COVID-19 in Africa tracker gathers the latest data on COVID-19 cases, deaths, as well as vaccine doses administered and manufactured.
The data on COVID-19 cases and deaths is collected from the COVID-19 Data Repository by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE) and Our World in Data (OWID). The data on vaccine doses administered so far is collected from OWID also. The data on vaccine manufacturing comes from the Launch & Scale Speedometer initiative by the Duke Global Health Innovation Center (DGHIC).
Last updated: 3 November 2022
COVID-19 confirmed cases and reported deaths in Africa (2 November 2022)
Highest number of new cases per 1M population
Lowest number of new cases per 1M population
13 other countries have seen no new cases, namely Cabo Verde, Cameroon, Central African Republic, Congo Republic, Djibouti, Egypt, Guinea, Guinea-Bissau, Lesotho, Malawi, Senegal, Seychelles and Zimbabwe
At the continental level, there has been a 21.7% increase in new cases as well as a 118% increase in new deaths during epidemiological week 43 (24-30 October 2022) compared to epidemiological week 42 (17-23 October 2022).
Eastern Africa (90.3%) and Southern Africa (28.4%) have seen an increase in new cases compared to the previous epidemic week, however there has been a decrease in new cases in Central Africa (-63.7%), Northern Africa (-19.8%) and Western Africa (-18.1%). New deaths have only increased in Southern Africa (267%) and Western Africa (100%) and decreased in Northern Africa (-83%) and Central Africa (-80%).
Over the last epidemic week, Southern Africa and Eastern Africa accounted for about 84% of new cases on the continent. Southern Africa accounted for approximately 92% of new deaths reported.
In absolute numbers, Southern Africa (5.6 million) and Northern Africa (3.8 million) are still the two regions with the most cumulative confirmed cases on the continent.
18 countries have no new cases per million over a seven-day moving average.
COVID-19 vaccine doses administered (2 November 2022)
Seychelles (201.1 per 100 people) has the 63rd highest number of doses per 100 people globally, yet 38 African countries are still in the bottom 50 with 33.8 doses per 100 people on average.
In terms of the absolute number of COVID-19 vaccine doses administered, Egypt ranks first in Africa and 23rd globally (more than 100 million) and the 10th highest number of doses administered per 100 people (90.4) on the African continent.
For the 53 African countries with data available, the African average currently stands at 57.7 doses per 100 people, and the median at 44.6.
High-income countries have purchased 2.7 times more doses than COVAX, even though COVAX is serving a population three times the size of that in high-income countries. Similarly, high-income countries have purchased more than 20 times more doses than the African Union’s COVID-19 Africa Vaccine Acquisition Trust (AVAT), even though they are both serving populations similar in size.
According to Our World in Data, only 13 countries have reached the 2021 year-end WHO target of fully vaccinating 40% of their people, namely: Mauritius (83.7%), Seychelles (75.9%), Rwanda (67.4%), Liberia (66.2%), Morocco (62.8%), Botswana (52.4%), Cabo Verde (52.1%), Tunisia (51.7%), Comoros (47.5%), São Tomé and Príncipe (45.5%), Mozambique (41%), Eswatini (40.8%) and Zimbabwe (40.4%). Mauritius and Seychelles are the only ones to have also reached the mid-2022 target of fully vaccinating 70% of their population.
Africa: highest number of COVID-19 vaccine doses administered per 100 people
Africa: lowest number of COVID-19 vaccine doses administered per 100 people
COVID-19 vaccine doses manufactured in Africa (9 June 2022)
Source: MIF based on Duke Global Health Innovation Center
Increasing the continent’s vaccine manufacturing capacities is key to end the pandemic. As of 9 June 2022, of the 48 countries globally where the main 23 COVID-19 vaccine brands are being manufactured, only four are African: Algeria, Egypt, Morocco and South Africa. According to the latest information publicly available, the majority of vaccines manufactured on the continent between 2021 and 2022 were in Egypt and South Africa (at least 320.1 and 250 million, respectively).
In 2021, the planned doses manufactured for those 23 COVID-19 vaccine brands accounted for over 12 billion globally. However, only 266.6 million were manufactured in Africa. This accounts for a meagre 2.2%.